Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)
Accessible Care Intervention for Engaging People Who Inject Illicit Drugs in HCV Care
Sponsor: City University of New York, School of Public Health
Listed as NCT03214679, this NA trial focuses on HCV Coinfection and Hepatitis C and remains completed. Sponsored by City University of New York, School of Public Health, it has been updated 10 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — Mar 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2019 — Aug 2020 [monthly]
Recruiting NA
-
Aug 2018 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- City University of New York, School of Public Health
- National Development and Research Institutes, Inc.
- National Institute on Drug Abuse (NIDA)
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .